Literature DB >> 8405397

Assembly of eukaryotic class III (N-out, C-in) membrane proteins into the Escherichia coli cytoplasmic membrane.

E S Hennessey1, L Hashemzadeh-Bonehi, L A Hunt, J K Broome-Smith.   

Abstract

Class III membrane proteins lack cleavable signal peptides but adopt an N-out, C-in topology with respect to their native membranes. We have analysed the fate of two eukaryotic class III plasma membrane proteins, human erythrocyte glycophorin C and influenza A virus M2 protein, in Escherichia coli. The N-terminal domains of both proteins were efficiently localised to the extracytoplasmic side of the bacterial cytoplasmic membrane. When beta-lactamase was fused to the C-terminus of glycophorin C it was localised to the cytoplasm, and protease treatment of spheroplasts caused a reduction in size of the fusion protein consistent with glycophorin C adopting its native topology in E. coli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405397     DOI: 10.1016/0014-5793(93)80317-n

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Membrane topology and insertion of membrane proteins: search for topogenic signals.

Authors:  M van Geest; J S Lolkema
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein.

Authors:  Cornelia Schroeder; Harald Heider; Elisabeth Möncke-Buchner; Tse-I Lin
Journal:  Eur Biophys J       Date:  2004-06-25       Impact factor: 1.733

3.  Translocation of N-terminal tails across the plasma membrane.

Authors:  G Cao; R E Dalbey
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

4.  Sec-independent translocation of a 100-residue periplasmic N-terminal tail in the E. coli inner membrane protein proW.

Authors:  P Whitley; T Zander; M Ehrmann; M Haardt; E Bremer; G von Heijne
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.